Coulter Translational Research Partners II Program
Welcome to the Coulter Translational Research Partners II Program at the University of Pittsburgh. This program is led and administered by the Swanson School of Engineering's Department of Bioengineering in partnership with the University of Pittsburgh School of Medicine and the Offices of Technology Management and Enterprise Development. Our mission is to identify, select, develop, and commercialize promising projects undertaken together by bioengineers and clinical faculty that address unmet clinical needs and better patient care worldwide. We will achieve this mission by either facilitating the licensing of these technologies or by enabling the formation of start-up ventures that obtain follow-on institutional funding.
The Wallace H. Coulter Translational Research Partners II (TPII) Program at Pitt funds translational research projects in healthcare, with the goal of accelerating the introduction of new technologies into patient care to address unmet clinical needs. Examples of desirable translational research projects and outcomes include systems and devices for the improved diagnosis and treatment of disease including both diagnostic and therapeutic solutions. Evaluation of each proposal will be on the basis of scientific and clinical merit, potential health care impact and significance, experience of the investigative co‐P.I.s and collaborators, timeline and pathway to commercialization and potential for obtaining further financial investment to translate the particular innovative technology to a healthcare solution.
For additional information visit the website at www.engineering.pitt.edu/coulter/#